Germany Circulating Tumor Cells Market Size & Outlook

The circulating tumor cells market in Germany is expected to reach a projected revenue of US$ 1,884.5 million by 2030. A compound annual growth rate of 12.4% is expected of Germany circulating tumor cells market from 2024 to 2030.
Revenue, 2023 (US$M)
$831.1
Forecast, 2030 (US$M)
$1,884.5
CAGR, 2024 - 2030
12.4%
Report Coverage
Germany

Germany circulating tumor cells market, 2018-2030 (US$M)

Germany

Germany circulating tumor cells market highlights

  • The Germany circulating tumor cells market generated a revenue of USD 831.1 million in 2023 and is expected to reach USD 1,884.5 million by 2030.
  • The Germany market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
  • In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
  • CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.


Circulating tumor cells market data book summary

Market revenue in 2023USD 831.1 million
Market revenue in 2030USD 1,884.5 million
Growth rate12.4% (CAGR from 2023 to 2030)
Largest segmentCtc detection & enrichment methods
Fastest growing segmentCTC Analysis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis
Key market players worldwideQiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies


Other key industry trends

  • In terms of revenue, Germany accounted for 7.2% of the global circulating tumor cells market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK circulating tumor cells market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 1,926.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Circulating Tumor Cells Market Companies

Name Profile # Employees HQ Website

Germany circulating tumor cells market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.


Ctc detection & enrichment methods was the largest segment with a revenue share of 65.59% in 2023. Horizon Databook has segmented the Germany circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.


The branded generic market in Germany is expected to witness positive growth over the forecast period due to government funding and investments to support generic drug manufacturing. According to a study published in 2020, the country depends on 63% of APIs imported from Asian countries and 33% from European countries for manufacturing of generic products.

In Germany, there is high penetration of generics and fierce competition among the players. Germany is among the mature players in the EU with penetration of generics at about 35% by value and around 75% by volume. From a reimbursement and a regulatory perspective, it is a tender-driven market, where quality and price are considered crucial criteria.

The increase in generics players in the country contributes to fierce competition and pricing pressures. In addition, physicians are not required to prescribe according to INN and might choose to avoid substitutes by prescribing specific brands, which is expected to drive the market growth in Germany.

Reasons to subscribe to Germany circulating tumor cells market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany circulating tumor cells market databook

  • Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany circulating tumor cells market , including forecasts for subscribers. This country databook contains high-level insights into Germany circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany circulating tumor cells market size, by technology, 2018-2030 (US$M)

Germany Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)

Germany circulating tumor cells market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more